03 / Clinical strategy and oversight
Clinical CRO & Bioequivalence
Clinical and preclinical strategy backed by day-to-day oversight of the vendors who run it. We keep bioequivalence and early-phase programs designed to succeed and managed to plan.
Clinical and preclinical strategy
Bioequivalence study design
Program design for early-phase and BE studies
CRO selection and oversight
IMP and clinical-supply management
Bioanalytical oversight
Clinical-BE program management
Have a program that needs clinical CRO and bioequivalence support? Tell us where it stands.
Credible partners for pharmaceutical & life-sciences clients. Evidence-led advisory in CMC, regulatory, quality and strategy for NCEs, generics and branded-generics.
© 2026 Credence Pharma Consulting Inc. All rights reserved.